Afinitor chemotherapy drug

Afinitor chemotherapy drug

C022/2467 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 50.5MB

Downloadable file size: 2.5MB

Price image Pricing

Please login to use the price calculator


Restrictions: Editorial use only Not to be shared on social media or embedded in a web page without permission.

Caption: Afinitor chemotherapy drug. Afinitor contains the substance Everolimus. Everolimus is a signal transduction inhibitor, a substance which blocks certain signals within cells that make them grow and divide. Everolimus inhibits a protein called mTOR (mammalian target of rapamycin) which controls other proteins that trigger cancer cells to proliferate. It is used to treat advanced kidney cancer, and certain kinds of pancreatic, brain and breast tumours.

Release details: Model release available. Property release not required.

Keywords: advanced, afinitor, biological therapy, box, brain, breast, cancer, chemotherapy, drug, everolimus, healthcare, kidney, mammalian target of rapamycin, medical, medicine, mtor, nurse, oncological, oncology, one person, pack, packaging, pancreatic, people, person, pharmaceutical, pharmaceutics, pharmacological, pharmacology, pills, prescribed, prescription, signal transduction inhibitor, tablet, treatment, tumours

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.